Lygos Revenue and Competitors

Location

$50M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Lygos's estimated annual revenue is currently $13.6M per year.(i)
  • Lygos's estimated revenue per employee is $155,000
  • Lygos's total funding is $50M.

Employee Data

  • Lygos has 88 Employees.(i)
  • Lygos grew their employee count by 29% last year.

Lygos's People

NameTitleEmail/Phone
1
Scientist IIIReveal Email/Phone
2
Senior Customer Success ManagerReveal Email/Phone
3
VP, Process Scaleup & ManufacturingReveal Email/Phone
4
Analytical Services ManagerReveal Email/Phone
5
Sr. Director, Brand MarketingReveal Email/Phone
6
Director FermentationReveal Email/Phone
7
System AdministratorReveal Email/Phone
8
VP Legal Affairs | Chief Patent CounselReveal Email/Phone
9
Senior AccountantReveal Email/Phone
10
CEO & Co-founderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Lygos?

Lygos employs cutting edge synthetic biology techniques to generate microbial catalysts to convert agricultural feedstocks into fine and commodity chemicals. Our robust high throughput screening and strain construction facilitates the rapid optimization of pathways to convert cheap and renewable feedstock to high value chemicals.

keywords:Clean Energy, Advanced Materials, Synthetic Biology, Specialty Chemicals

$50M

Total Funding

88

Number of Employees

$13.6M

Revenue (est)

29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lygos News

2022-04-19 - Form SC 13D FLEXIBLE SOLUTIONS INTER Filed by: LYGOS ...

(Name of Issuer). Common Stock. (Title of Class of Securities). 33938T104. (CUSIP Number). Eric Steen. Chief Executive Officer. Lygos, Inc.

2022-04-19 - SHAREHOLDER ALERT: Weiss Law Reminds FSI, NTUS ...

Under the terms of the merger agreement, Lygos issued $160 million worth of convertible notes with a 5.5% fixed annual interest rate and a...

2022-04-13 - Lygos and Flexible Solutions International Announce ...

Lygos has created a biological engineering platform focused on sustainable production of organic acid bio-monomers. Lygos' bio-based ingredients...

2019-06-03 - Lygos Awarded $2 Million Grant to Develop Artificial Intelligence and Machine Learning Technologies to Revive U.S. Biomanufacturing

Partnership with U.S. Department of Energy and Agile BioFoundry to accelerate microbial engineering for cost-competitive production of new biochemicals June 03, 2019 08:00 AM Eastern Daylight Time BERKELEY, Calif.--(BUSINESS WIRE)--Lygos, Inc., a full-stack producer of specialty chemicals that d ...

2019-01-23 - Lygos Receives $5M Investment from LG Technology Ventures

Lygos, Inc., a Berkeley, CA-based biotechnology-based producer of specialty chemicals that deliver high-value performance without environmental toxicity, received a $5m investment from LG Technology Ventures, the investment arm of the South Korean conglomerate LG Group. The deal was part of the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.6M884%N/A
#2
$11.4M88-16%$9M
#3
$3.5M8941%N/A
#4
$24M89-13%N/A
#5
$7.5M8914%N/A